Skip to main content
logo
Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
4.210
-0.100 (-2.32%)
Aug 28, 2026, 4:00 PM EDT - Market closed

Psyence Biomedical Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
7.446.140.731.331.76
Cash & Short-Term Investments
7.446.140.731.331.76
Cash Growth
21.35%736.78%-45.05%-23.97%-
Other Receivables
0.110.140.040.150.04
Receivables
0.360.140.040.150.04
Prepaid Expenses
1.260.250.320.080.01
Restricted Cash
0.050.040.030.030.03
Total Current Assets
9.116.561.131.591.83
Property, Plant & Equipment
0.010.010.01--
Long-Term Investments
8.060.75---
Other Long-Term Assets
0.39----
Total Assets
17.577.321.131.591.83

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
0.230.260.561.630.04
Accrued Expenses
0.080.050.130.160.09
Short-Term Debt
--10.45--
Other Current Liabilities
0.310.280.97--
Total Current Liabilities
0.620.5912.11.790.13
Total Liabilities
0.620.5912.11.790.13

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
78.7561.7546.135.931.7
Retained Earnings
-63.38-56.45-57.46-6.3-
Comprehensive Income & Other
1.581.420.360.17-
Shareholders' Equity
16.946.72-10.97-0.21.7
Total Liabilities & Equity
17.577.321.131.591.83

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
--10.45--
Net Cash (Debt)
7.446.14-9.711.331.76
Net Cash Growth
21.35%---23.97%-
Net Cash Per Share
13.48198.63---
Filing Date Shares Outstanding
3.810.09---
Total Common Shares Outstanding
2.290.09---
Working Capital
8.495.97-10.98-0.21.7
Book Value Per Share
7.3973.96---
Tangible Book Value
16.946.72-10.97-0.21.7
Tangible Book Value Per Share
7.3973.96---
Machinery
0.020.020.01--
SEC Filings: 10-K · 10-Q